AMERISAFE Reports Q1 Profit Decline Despite Premium Growth; Repurchases $4M in Shares
summarizeSummary
AMERISAFE, Inc. announced a decline in Q1 2026 net income and diluted EPS by 9.0% and 8.5% respectively, despite a 9.0% increase in net premiums earned. The company also repurchased $4.0 million in shares and declared a quarterly dividend.
check_boxKey Events
-
Q1 Profitability Decline
Net income decreased 9.0% to $8.145 million, and diluted EPS fell 8.5% to $0.43, compared to the prior year. Operating EPS saw a steeper decline of 16.7%.
-
Premium Growth Reported
Gross premiums written increased 5.6% to $88.5 million, and net premiums earned grew 9.0% to $75.072 million, marking the eighth consecutive quarter of growth.
-
Worsening Underwriting Performance
The net combined ratio increased to 93.2% from 89.1% in Q1 2025, driven by a higher net loss ratio, indicating less profitable underwriting.
-
Capital Returns Continue
The company repurchased 119,959 shares for $4.0 million and declared a quarterly cash dividend of $0.41 per share, representing a 5.1% increase from the prior year.
auto_awesomeAnalysis
AMERISAFE's first-quarter results show a concerning trend of declining profitability, with net income and diluted EPS falling year-over-year, and operating EPS seeing an even steeper drop. This comes despite healthy growth in gross and net premiums, and improved expense discipline. The worsening net combined ratio indicates less profitable underwriting, which is a key concern for an insurance company. While the company continues to return capital to shareholders through increased dividends and a $4.0 million share repurchase, the core earnings performance is a negative signal, especially with the stock trading near its 52-week low. Investors will be watching if the premium growth can eventually translate into improved bottom-line results and a better combined ratio in future quarters.
At the time of this filing, AMSF was trading at $33.15 on NASDAQ in the Finance sector, with a market capitalization of approximately $623.1M. The 52-week trading range was $32.00 to $50.07. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.